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2Abstract
Here we report on the synthesis of very small -Fe2O3 nanoparticles (5 nm) presenting very 
narrow particle size distribution and exceptionally high saturation magnetisation. The 
synthesis has been carried out in an organic medium with subsequent transfer to an 
aqueous solution at physiological pH. The structural and magnetic properties were kept 
unaltered after the solvent exchange. NMR relaxometric measurements show the potential 
of these particles as specific reporters for magnetic resonance molecular imaging. 
3Introduction
Magnetic resonance imaging (MRI) is a medical technique widely employed in many 
clinical practices due to its capability to enhance contrast differences between healthy and 
pathological tissues. Images of body sections precisely reflect the variation in the proton 
density, longitudinal or transversal relaxation time, T1 or T2 of the tissues. Despite the 
inherent versatility of this imaging modality, researchers and clinicians are dedicating huge 
efforts to develop safer and more effective contrast agents (CAs) that will expand the 
diagnostic utility and improve the precision of MRI. The main application of CAs relies on 
the shortening of the relaxation times of the water protons. Positive contrast agents reduce 
T1 resulting in a brighter signal, while negative contrast agents reduce T2 resulting in a 
darker signal. The reciprocals of the relaxation times are called the relaxation rates, R1 and 
R2, with the effectiveness of a CA expressed as relaxivities, r1 and r2, i.e. the rate(s) 
enhancement(s) brought per mM of metal.
A large number of compounds, mostly paramagnetic substances, have been assayed as 
potential MRI contrast agents1,2. Gadolinium chelates, such as Gd-DTPA, constitute the 
largest group of paramagnetic MR T1-contrast agents and are considered to be safe and 
effective3-5. Iron oxides (magnetite and maghemite) play an important role as MR T2-
contrast agents due to their sizes and magnetic properties. Various iron oxide nanoparticles 
have been synthesised and evaluated as CAs6-9. They mainly differ in the iron oxide phase, 
the magnetic core size or in the type of coating material used (dextran, albumin, silicones, 
and poly(ethylene glycol)). For those systems, the reported hydrodynamic mean diameter 
ranges from 10 up to 3500 nm. 
In recent years, considerable advances have been made in high-resolution in vivo imaging 
methods for monitoring specific molecular or cellular processes. For this purpose and due 
4to the limited number of targets, high relaxivity values and high specificity of the CAs are 
necessary. When using Gd-based contrast agents, a large number of paramagnetic centres 
(high concentration of metal) are often needed to reach a sufficient detection level10-12. 
Owing to the large number of iron atoms per crystal, superparamagnetic nanoparticles of 
iron oxide have strong T2 and T2* effects and therefore can be useful to image low 
concentrations of a specific molecular process13-14. In spite of their widespread 
applications, inherent problems of iron-oxide systems remain unsolved or difficult to 
address. The most prominent ones are a broad particle size distribution, lack of crystal 
phase identification, low value of the saturation magnetisation of the nanoparticles as 
compared to the bulk materials, particle aggregation in a magnetic field and particle 
sedimentation in physiological media. Moreover, as the negative contrast agents induce 
signal voids (darkening) in the image, a fundamental drawback is that the agent cannot be 
distinguished in a naturally dark area. A new method for imaging, recently reported by 
Cunningham et al.15, enables the use of iron oxide nanoparticles as T1-contrast agents. In 
such context, very small particles are needed (5-10 nm). 
The aim of this work is to investigate the use of the ultrasmall maghemite nanoparticles 
with very narrow size distribution and high magnetisation as MR T1-contrast agents. Here, 
we report on the synthesis of the nanoparticles, based on the decomposition of Fe(CO)5 in 
hydrocarbon solvents16, as well as its thorough physico-chemical characterisation. In order
to stabilise the particles in a physiological environment, they have been transferred to an 
aqueous medium using an ammonium salt and stabilized with addition of sodium citrate at 
neutral pH. The nanoparticles remained quite monodisperse, as characterised by TEM and 
XRD, as well as superparamagnetic at room temperature, as determined by magnetic 
measurements. The relaxometric measurements performed suggest the potential use of this 
5system as a T1-contrast agent due to the high magnetisation of the nanoparticles at clinical 
field strengths. After functionalisation with specific biological ligands, these iron oxide 
nanoparticles could be used as molecular imaging probes17. 
Experimental
Materials
Iron pentacarbonyl (Fe(CO)5, 99.999%), oleic acid (99%), dioctyl ether (99%), 
tetramethylammonium hydroxide (TMAOH, 25 wt. % in H2O), sodium citrate, potassium 
dichromate (K2Cr2O7, 1/25 M in H2O), tin (II) chloride (SnCl2, 98%), mercury (II) chloride 
(HgCl2, 99.5%), sodium diphenylamine-4-sulfonate and chloric acid (HCl, 37%) were 
purchased from Sigma Aldrich (Spain) and used as received without further purification.
Synthesis of hexane-dispersed maghemite nanoparticles
Maghemite nanoparticles were synthesised by decomposition of iron pentacarbonyl in 
dioctyl ether, in the presence of oleic acid, a non-polar surfactant. Briefly, 0.32 ml (1 
mmol) of oleic acid were added to 20 ml of dioctyl ether (solvent) and heated under argon 
atmosphere up to 90ºC. Then, 0.1 ml (0.75 mmol) of Fe(CO)5 was added to the reaction 
mixture. The temperature was raised to 300ºC and kept constant for 30 minutes. 
Afterwards, the mixture was allowed to cool to room temperature. In order to isolate the 
nanoparticles from the reaction medium, 40 ml ethanol were added to precipitate the 
particles. The mixture was centrifuged and the black precipitate was recovered in 20 ml of 
hexane, followed by another centrifugation to allow the precipitation of any insoluble 
impurities. The solution was recovered and stored tightly closed and hereafter is referred to 
as Fe2O3-hexane. 
6Stabilisation of maghemite nanoparticles at physiological pH 
To stabilise the particles in an aqueous solution the organic non-polar surfactant was 
displaced by the electrolyte, tetramethylammonium hydroxide (TMAOH). 5 ml of an 
aqueous solution of TMAOH (1.71 wt% in water) were added to 5 ml of the hexane iron 
oxide dispersion. The mixture was stirred during 12 hours. The nanoparticles were 
recovered by precipitation with acetone, followed by centrifugation. The supernatant was 
then discarded, and the precipitate was resuspended in 0.02 ml TMAOH and water was 
added to bring the total volume to 5 ml. The material was stored and hereafter is referred to 
as Fe2O3-water. After addition of 0.02 ml of TMAOH (25 wt% in water) and 8 mg (0.03 
mmol) of sodium citrate to a 0.5 ml of Fe2O3-water solution, the pH was brought to neutral
pH by adding 0.1 M HNO3 dropwise. The sample then got clear and stable and hereafter is 
referred to as Fe2O3-citrate.
Characterisation of magnetic nanoparticles
Transmission electron microscopy (TEM) and electron diffraction.
A JEOL JEM-1210 Electron Microscope, operating at 120 keV, was used for the electron 
diffraction analysis and the transmission electron microscopy. The samples for electron 
microscopy were prepared by deposition of a droplet of the nanoparticle solution onto a 
carbon-coated film supported on a copper grid and allowed to dry.
X-Ray Diffraction (XRD).
Fe2O3-water sample (after freeze-drying) was characterised by X-ray diffraction with a 
Siemens D5000 X-ray powder diffractometer using a Cu K incident radiation. XRD 
patterns were analysed by Rietveld refinement with the MAUD program18. 
7Dynamic light scattering (DLS) and -potential.
Dynamic light scattering and -potential measurements were performed with a Zetasizer 
Nano ZS (Malvern Instruments), provided with a He/Ne laser of 633 nm wavelength. The 
determination of the isoelectric point, IEP, was performed using the MPT-2 Autotitrator, 
an accessory of the Zetasizer Nano ZS. The samples were further dissolved 20 times before 
the measurements of the isoelectric point.   
Infrared spectroscopy (IR).
IR spectra (4000-400 cm-1) from KBr discs of Fe2O3 aqueous solutions (after freeze-drying 
the aqueous solution) and of Fe2O3 in hexane solution (after evaporating the solvent) were 
recorded on a Fourier transform Perkin-Elmer spectrometer. 
Magnetic measurements.
Hysteresis loops of the Fe2O3 aqueous solutions at room temperature were performed in a 
magnetometer VSM-NUVO, MOLSPIN, Newcastle Upon Tyne, UK. For the frozen 
Fe2O3-water sample, hysteresis loops at 5 K and the zero field cool-field cool (ZFC-FC) 
curves were measured with a superconducting quantum interference device (SQUID) 
magnetometer (Quantum Desing MPMS5XL). The experimental results were corrected for 
the holder contribution and for a temperature-independent diamagnetic contribution. All 
the magnetisation data are presented in Am2/kg Fe2O3.
Relaxometric measurements.
The NMRD (Nuclear Magnetic Resonance Dispersion) profiles were recorded from 10 
kHz to 10 MHz on a Stelar field cycling relaxometer (Stelar, Mede, Italy). Additional 
measurements at 20 and 60 MHz were performed on a Bruker Minispec system (Bruker, 
Karlsruhe, Germany). The stability of the Ti relaxation times was assessed by repeating the 
8Ti measurements of one sample at several times (24, 48 and 36 hours). No relaxivity 
changes were detected.
Total iron concentration.
The iron concentration in 0.2 ml for the Fe2O3 aqueous solutions was determined by 
relaxometry measurements at 20 MHz and 330 K after mineralization in acidic conditions 
(0.6 ml HNO3 and 0.3 ml H2O2) by microwaves (Milestone MSL-1200, Sorisole, Italy).
The evidence of the Fe2+ ion in Fe2O3-water solution was determined by titration with 
potassium dichromate (K2Cr2O7).
Results and discussion 
Characterisation of Fe2O3-hexane nanoparticles
Iron oxide nanoparticles, crystalline and monodisperse, have been synthesised from the 
decomposition of the Fe(CO)5 in an organic solvent. Oleic acid creates a shell around the 
inorganic iron oxide core through the carboxylate oxygens resulting in a steric repulsion 
between the particles thus preventing their aggregation and precipitation. Transmission 
electron micrograph of Fe2O3-hexane solution showed rather spherical, monodisperse and 
well-formed nanocrystals (see Fig. 1A). By measuring more than 260 particles the mean 
diameter obtained is 4.9 ± 0.7 nm, with a standard deviation of 14% (see Fig. 1B), where 
94% of the particles display sizes between 3.5 and 5.75 nm, and none of them were larger 
than 8 nm. It has to be noted that for very small particle sizes (~ 5 nm) a difference of 0.5 
nm in diameter already means a standard deviation of 10%. High crystallinity of the 
magnetic particles is deduced from the good definition of the electron diffraction ring 
pattern (see Fig. 1C). It corresponds to a polycrystalline diffraction pattern (the electron 
beam is larger than a single particle). The diffraction rings can be equally well indexed 
9considering any of the two iron oxide crystal structures: maghemite (-Fe2O3) or magnetite 
(Fe3O4). Complementary analyses have been carried out to discern which one of the 
structures is present in our sample (results shown in the next section). 
Characterisation and stabilisation of Fe2O3-water nanoparticles
Before these particles can act as contrast agents, they must be stabilised in a physiological 
aqueous environment. The redispersion of Fe2O3-hexane nanoparticles in water requires 
the removal of the surfactant layer, oleic acid, and subsequent replacement with TMAOH. 
Fig. 2 shows a photograph of Fe2O3-hexane (top of the two-phase mixture, Fig. 2A)) and of 
Fe2O3-water (bottom of the two-phase mixture, Fig. 2B); that is, before and after the phase 
transfer. In both cases the iron concentration was measured, obtaining the same value in 
hexane and in water solution, pointing to an exchange yield of 100%. 
X-ray diffraction was performed to a lyophilised aliquot of the Fe2O3-water sample. 
Because of the modest amount of available sample and the small size of the crystalline 
particles, the peaks of the diffractogram are not very well defined (see supplementary 
data). They can be indexed either to maghemite or magnetite. The calculated crystallite 
size, according to the Rietveld refinement of the pattern, was 5 ± 1 nm, both for maghemite 
and magnetite, a value which is in agreement with the one obtained by TEM (results not 
shown).
In order to discern if our iron oxide particles are built up of magnetite (Fe3O4 
2Fe3+Fe2+4O2-) or maghemite (Fe2O3  2Fe3+3O2-), the existence of Fe2+ ions was 
determined by the titration with potassium dichromate. No significant Fe2+ ion 
concentration was determined, suggesting the maghemite phase as the crystalline phase. 
Moreover, the solution presents a red colour, as it is expected for maghemite solutions.
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Keeping in mind the biological applications, it was necessary to decrease the pH value 
from basic to neutral pH. For this purpose, nitric acid (HNO3) was used also in the 
presence of citrate sodium in order to avoid the agglomeration and precipitation of the 
nanoparticles at pH lower than 8. 
TEM images were also performed for Fe2O3-citrate resulting in the same particle 
characteristics as before (see Fig. 3A). The mean particle diameter was 4.8 ± 0.6 nm, with 
a standard deviation of 12%, where 98% of the particles display sizes between 3.25 and 
5.75 nm (see Fig. 3B), being the largest particles 6.25 nm in diameter. The electron 
diffraction pattern (see Fig. 3C) displays the same diffraction rings as before. The results 
suggest that no physico-chemical changes occurred during the organic solvent-water 
exchange. 
The hydrodynamic diameter, dHYD, is a useful measurement that will define the final 
biological application of the material studied. Dynamic light scattering size measurements 
were performed for the three samples: Fe2O3-hexane, Fe2O3-water and Fe2O3-citrate, 
resulting in hydrodynamic diameters of 12  2 nm, 8  2 nm and 18  4 nm, respectively. 
We interpret the increase in size for the Fe2O3-citrate sample as due to incorporation of the 
citrate ligands at the surface of the iron particles that may induce some aggregation 
between pairs of particles.
Subsequently, the zeta potential () and the isoelectric point (IEP) for the Fe2O3 aqueous 
solutions were estimated. The zeta potential value can be used as an indicator of the 
stability of a colloidal system. The higher the  absolute values, the higher the net 
electrical charge onto the surface of the particles and, therefore, the larger the electrostatic 
repulsion between particles. The theoretical limit of stability is |30| mV, i.e. a colloidal 
system will be stable if its zeta potential is higher than 30 mV or lower than -30 mV. The 
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isoelectric point (IEP) specifies the pH at which the net electrical charge onto the surface 
of the particles is zero, i.e., the pH of lowest stability of the system19. In Fig. 4, the 
behaviour of the zeta potential for the Fe2O3-water and for the Fe2O3-citrate versus the pH 
is shown. For the Fe2O3-water,  is lower than -30 mV for pH > 7.5, and higher than 30 
mV for pH < 4.3, with an isoelectric point of 6.1, suggesting a lack of stability in the range 
of physiological pH. The addition of citrate shifts the isoelectric point down to 1.7. This 
system will be stable at pH higher than 4.1. We believe that this is a result of adsorption of 
citrate anions to the positively charged particle surface, which then enables the stabilisation 
of the particles at neutral pH. 
Finally, a clear evidence of the removal of the organic layer from the surface of the 
particles was also provided by FTIR spectroscopy measurements of dried samples mixed 
with KBr. In the case of the hydrophobic particles, oleic acid is observed, while in aqueous 
solution, for Fe2O3-water and for Fe2O3-citrate, the organic ligand has been replaced by 
TMAOH. Further, the spectrum of the Fe2O3-citrate shows clearly the adsorption of citrate 
anions but still conserving some of the TMAOH ligands (see supplementary data). 
Magnetic measurements of the Fe2O3-water sample are shown in Fig. 5. The magnetisation 
curve at room temperature plotted on Fig. 5 shows that the Fe2O3-water sample exhibits 
superparamagnetic behaviour deduced by the zero coercitive field and the zero remanent 
magnetisation values. At 5 K, the maghemite nanoparticles show the expected 
ferrimagnetic behaviour with a coercive field of 96 Oe (see lower inset in Fig. 5). The 
sample is already saturated at 10 kOe, with a saturation magnetisation value (MS) of 74 
Am2/kg Fe2O3. Data at room temperature were fitted to a Langevin function obtaining the 
following values: MS = 68 Am
2/kg and dmag = 5 nm, results which are in good agreement 
with TEM measurements, and a magnetisation saturation value only 10% lower than the 
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value for the bulk material (lit.,20 76 Am2/kg Fe2O3 at 298 K). Interestingly enough, our 
iron oxide nanoparticles exhibit a strong induced magnetisation, close to the bulk value, 
even after decreasing their size up to 5 nm contrasting with the low saturation 
magnetisation reported in many other maghemite particulated systems21-23.
The zero field cool - field cool (ZFC-FC) curves of the Fe2O3-water sample (upper inset in 
Fig. 5) describe the temperature dependence of the magnetisation. The ZFC curve gives 
information about the ferri-superparamagnetic transition of the system, which occurs at the 
temperature of the maximum magnetisation value, the blocking temperature (TB). For our 
system a TB value of 15 K was obtained. The splitting of the curves just below TB and the 
sharp maximum of the ZFC curve once more stand for a very narrow particle size 
distribution. 
No significant changes in the magnetic behaviour were detected when comparing the 
above described results with the ones obtained for the Fe2O3-citrate system (see 
supplementary data). The shape of the magnetisation loop at room temperature for the 
Fe2O3-citrate system also points out to a superparamagnetic system with a saturation 
magnetisation value of 65 Am2/kg Fe2O3, confirming the magnetic stability of the sample 
at different pHs. 
Some physical properties of Fe2O3-water and of Fe2O3-citrate are summarised in Table 1. 
As previously mentioned, MR contrast agents act by shortening the relaxation times of the 
surrounding protons, T1 and T2, because of their inherent magnetic properties. The 
effectiveness of a CA is usually expressed as relaxivities, r1 and r2, per mM of metal. 
Relaxivities of Fe2O3-water nanoparticles placed in water with TMAOH are shown in 
Table 2. r1 values are higher than those observed for the paramagnetic complexes, such as 
Gd-DTPA, due to its high magnetisation, while r2 values are much lower than values 
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observed for the superparamagnetic particles of larger size. The magnitude of r1 is 
dependent on the magnetisation of the CA, the electron spin relaxation, the size of the 
magnetic crystal and the accessibility to the CA of bearing nuclear spins of the tissue. The 
magnitude of r2 reflects the ability of the CA to produce local magnetic inhomogeneities. 
At high field r1 decreases while r2 increases when the diameter of the crystal is larger. The 
ratio r2/r1 is therefore an indicator of the relaxometric properties of the CA and it serves to 
classify the type of MR CA as T1-CA or T2-CA
6. In general, for paramagnetic chelates r2/r1
varies between 1-2 and for the superparamagnetic colloids it can be as large as 50. Because 
of the small size of the iron oxide particles evaluated, the ratio r2/r1 corresponds to the 
typical values expected for paramagnetic complexes. 
Relaxivity measurements of the Fe2O3-citrate were also performed (see Table 3). In 
comparison with relaxivity values of Fe2O3-water, the r1 values for Fe2O3-citrate are 
similar but the r2 values have increased. This increase of the ratio r2/r1 can be considered as 
an indicator of the clustering between particles24. This observation matches very well with 
the hydrodynamic ratio measurements which also indicated pairing of the particles when 
coated with citrate. 
In order to understand and quantify the mechanisms governing the relaxation phenomenon 
of the system, a nuclear magnetic relaxation dispersion (NMRD) profile was recorded and 
fitted according to the usual model25. The NMRD profile displays r1 over a wide range of 
magnetic fields and provides the information necessary to asses the properties of a contrast 
agent at any field strength. It also gives information on the particle diameter (d) and the 
value of the saturation magnetization (Ms). The relaxivity profile (r1) of Fe2O3-water 
nanoparticles is represented in Fig. 6. The relaxivity, r1, of this complex behaves as 
expected for ultrasmall superparamagnetic particles. The high field inflexion point named 
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dispersion of the longitudinal relaxation profile is roughly given by the condition iD = 1 
in which D = r2/D with r being the radius of the crystal and D the relative diffusion 
coefficient of water with respect to the particle. D is the diffusion correlation time which 
defines the time during which the diffusing proton is influenced by the superparamagnetic 
particle. After the high field dispersion, the longitudinal relaxation decreases rapidly to 
zero. The NMRD profile was analysed quantitatively according to equation 31 (lit.25) and 
the values obtained from the fitting are summarised in Table 4. Theoretical values obtained 
from the fitting are in good agreement with those obtained by other techniques, pointing 
once more to a very narrow distribution of the particle size and showing consistency within 
all the used characterisation techniques. 
Conclusions
The present investigation focused on the study of new contrast agents for molecular 
imaging. Ultrasmall iron-oxide nanoparticles with a very narrow particle size distribution 
and a high saturation magnetisation value have been obtained. They have been stabilised in 
water at physiological pH and tested as T1 MRI contrast agents. After functionalization 
with biological ligands these nanoparticles could be used as magnetic reporters for 
molecular imaging probes.
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Figure 1. (A) TEM images of Fe2O3-hexane. (B) Particle size distribution histogram. (C) 
Selected area electron diffraction (SAED) pattern with indexed planes.
Figure 2. Photograph of two-phase mixtures with Fe2O3 nanoparticles dispersed in hexane 
(A) and in water (B).
Figure 3. (A) TEM images of Fe2O3-citrate. (B) Particle size distribution histogram. (C) 
Selected area electron diffraction (SAED) pattern with indexed planes. 
Figure 4. Behaviour of the Zeta Potential versus pH for the Fe2O3-water and Fe2O3-citrate 
samples. 
Figure 5. Main panel: magnetisation curves at 298 K (circles) and 5 K (squares) for the 
Fe2O3-water sample. Upper inset: ZFC-FC curves. Lower inset: enlargement of the 
magnetisation loop at 5 K.
Figure 6. 1H NMRD profile of the Fe2O3-water sample at 310 K.
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Tables
Table 1
Physical properties of Fe2O3-water and Fe2O3-citrate solutions
TEM: transmission electronic microscopy; XRD: X-Ray diffraction; HYD: hydrodynamic; 
IEP: isoelectric point; MS: saturation magnetisation; HC: coercive field; TB: blocking 
temperature.
dTEM (nm)                           4.9 ± 0.6                    4.8 ± 0.6
dXRD (nm)                             5 ± 1
dHYD (nm)                             8 ± 2                        18 ± 4
Crystalline phase                -Fe2O3                     -Fe2O3
Colour of solution                   red                             red
IEP (pH unities)                      6.1                             1.7
pH                                          12.5                            7.4
Ms (Am2/kg) at 298 K            68                               65
Hc (Oe) at 5 K                         96                              73
TB (K)                                      15                              11
Physical property           Fe2O3-water            Fe2O3-citrate
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Table 2
Relaxivity values of Fe2O3-water solutions at basic pH and 310 K
r1 (mM-1s-1)          r2 (mM-1s-1)         r2/r1
20 MHz             20.81                    28.61              1.38
60 MHz             17.59                    35.75              2.03
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Table 3
Relaxivity values of Fe2O3-citrate solutions at neutral pH and 310 K
r1 (mM-1s-1)          r2 (mM-1s-1)         r2/r1
20 MHz             20.76                    51.02              2.46
60 MHz             14.50                    66.90              4.61
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Table 4
Parameters obtained from the fittings of the NMRD profile at 310 K for the Fe2O3-water 
sample.
adiameter and MS from NMRD profile; 
bdiameter from TEM measurements; cdiameter and 
MS from magnetic measurements
da (nm)           Msa                    db (nm)              Msc                   db (nm)
                 (Am2/ kg Fe2O3)                              (Am2/ kg Fe2O3)
5.7                 73                         4.9                 68                     5
NMRD profile               TEM           Magnetic measurements
